FEMY
FEMASYS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$2.59
+1.57%Next report
Analyst consensus
- Next report date
- Nov 17, 2026
- EPS estimate
- -$0.47
- Revenue estimate
- $763.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.33
- EPS estimate
- -$1.31
- Revenue actual
- $331.8K
- Revenue estimate
- $730.7K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +51.7%
- Revenue beats (12Q)
- 0
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $10
- PT range
- $10 – $10
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.31 | -$1.33 | Miss -1.53% | $331.8K |
| May 8, 2026 | -$0.07 | $0.00 | Beat 107.35% | $424.9K |
| Mar 31, 2026 | -$0.08 | -$0.01 | Beat 88.00% | $813.4K |
| Nov 14, 2025 | -$0.12 | -$0.10 | Beat 13.04% | $729.4K |
| Aug 8, 2025 | -$0.18 | -$0.16 | Beat 11.11% | $409.3K |
| May 8, 2025 | -$0.17 | -$0.23 | Miss -35.29% | $341.3K |
| Mar 27, 2025 | -$0.25 | -$0.23 | Beat 8.00% | $581.6K |
| Aug 8, 2024 | -$0.18 | -$0.21 | Miss -16.67% | $221.5K |
| May 9, 2024 | -$0.22 | -$0.17 | Beat 22.73% | $271.1K |
| Nov 14, 2023 | -$0.25 | -$0.26 | Miss -4.00% | $244.4K |
| Aug 10, 2023 | -$0.19 | -$0.22 | Miss -15.79% | $320.5K |
| May 11, 2023 | -$0.26 | -$0.25 | Beat 3.85% | $294.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 17, 2026